121 related articles for article (PubMed ID: 9197351)
1. The Nordic multicenter double-blind randomized controlled trial of prophylactic ursodeoxycholic acid in liver transplant patients.
Keiding S; Høckerstedt K; Bjøro K; Bondesen S; Hjortrup A; Isoniemi H; Erichsen C; Söderdahl G; Ericzon BG
Transplantation; 1997 Jun; 63(11):1591-4. PubMed ID: 9197351
[TBL] [Abstract][Full Text] [Related]
2. A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection.
Barnes D; Talenti D; Cammell G; Goormastic M; Farquhar L; Henderson M; Vogt D; Mayes J; Westveer MK; Carey W
Hepatology; 1997 Oct; 26(4):853-7. PubMed ID: 9328304
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant treatment with ursodeoxycholic acid reduces acute rejection after liver transplantation.
Friman S; Persson H; Scherstén T; Svanvik J; Karlberg I
Transpl Int; 1992; 5 Suppl 1():S187-9. PubMed ID: 14621771
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group.
Poupon RE; Eschwège E; Poupon R
J Hepatol; 1990 Jul; 11(1):16-21. PubMed ID: 1975819
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
Assy N; Adams PC; Myers P; Simon V; Minuk GY; Wall W; Ghent CN
Transplantation; 2007 Jun; 83(12):1571-6. PubMed ID: 17589339
[TBL] [Abstract][Full Text] [Related]
6. A prospective, randomized, double-blind trial evaluating the efficacy of ursodeoxycholic acid in prevention of liver transplant rejection.
Fleckenstein JF; Paredes M; Thuluvath PJ
Liver Transpl Surg; 1998 Jul; 4(4):276-9. PubMed ID: 9649640
[TBL] [Abstract][Full Text] [Related]
7. A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid.
Vuoristo M; Färkkilä M; Karvonen AL; Leino R; Lehtola J; Mäkinen J; Mattila J; Friman C; Seppälä K; Tuominen J
Gastroenterology; 1995 May; 108(5):1470-8. PubMed ID: 7729640
[TBL] [Abstract][Full Text] [Related]
8. Evidence that ursodeoxycholic acid prevents steroid-resistant rejection in adult liver transplantation.
Clavien PA; Sharara AI; Camargo CA; Harland RC; Fitz JG
Clin Transplant; 1996 Dec; 10(6 Pt 2):658-62. PubMed ID: 8996761
[TBL] [Abstract][Full Text] [Related]
9. A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis.
Oka H; Toda G; Ikeda Y; Hashimoto N; Hasumura Y; Kamimura T; Ohta Y; Tsuji T; Hattori N; Namihisa T
Gastroenterol Jpn; 1990 Dec; 25(6):774-80. PubMed ID: 1980654
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant treatment with ursodeoxycholic acid may reduce the incidence of acute cardiac allograft rejection.
Bährle S; Szabó G; Stiehl A; Theilmann L; Dengler TJ; Zimmermann R; Kübler W
J Heart Lung Transplant; 1998 Jun; 17(6):592-8. PubMed ID: 9662095
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a short-term, randomized, double-blind controlled, cross-over study with long-term follow up.
Hwang SJ; Chan CY; Lee SD; Wu JC; Tsay SH; Lo KJ
J Gastroenterol Hepatol; 1993; 8(3):217-23. PubMed ID: 8100153
[TBL] [Abstract][Full Text] [Related]
12. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant treatment with ursodeoxycholic acid prevents acute rejection in rats receiving heart allografts.
Olausson M; Mjörnstedt L; Wramner L; Persson H; Karlberg I; Friman S
Transpl Int; 1992; 5 Suppl 1():S539-41. PubMed ID: 14621870
[TBL] [Abstract][Full Text] [Related]
14. Liver disease associated with ZZ alpha1-antitrypsin deficiency and ursodeoxycholic acid therapy in children.
Lykavieris P; Ducot B; Lachaux A; Dabadie A; Broué P; Sarles J; Bernard O; Jacquemin E
J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):623-9. PubMed ID: 18955864
[TBL] [Abstract][Full Text] [Related]
15. Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis.
Heathcote EJ; Stone J; Cauch-Dudek K; Poupon R; Chazouilleres O; Lindor KD; Petz J; Dickson ER; Poupon RE
Liver Transpl Surg; 1999 Jul; 5(4):269-74. PubMed ID: 10388499
[TBL] [Abstract][Full Text] [Related]
16. A possible role of ursodeoxycholic acid in liver transplantation.
Friman S; Svanvik J
Scand J Gastroenterol Suppl; 1994; 204():62-4. PubMed ID: 7824880
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation.
Ruutu T; Eriksson B; Remes K; Juvonen E; Volin L; Remberger M; Parkkali T; Hägglund H; Ringdén O;
Blood; 2002 Sep; 100(6):1977-83. PubMed ID: 12200355
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study.
Spagnuolo MI; Iorio R; Vegnente A; Guarino A
Gastroenterology; 1996 Sep; 111(3):716-9. PubMed ID: 8780577
[TBL] [Abstract][Full Text] [Related]
19. Bezafibrate for primary biliary cirrhosis.
Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2012 Jan; 1():CD009145. PubMed ID: 22259000
[TBL] [Abstract][Full Text] [Related]
20. Effect of ursodeoxycholic acid treatment for cholestasis in liver transplant recipients.
Rafael E; Duraj F; Rudström H; Wilczek H; Ericzon B
Transplant Proc; 1995 Dec; 27(6):3501-2. PubMed ID: 8540069
[No Abstract] [Full Text] [Related]
[Next] [New Search]
